{
    "Trade/Device Name(s)": [
        "Control Set DAT I",
        "Control Set DAT II",
        "Control Set DAT III",
        "Control Set Amphetamine 1000",
        "Control Set Amphetamine 500"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K080183",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070200"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "DIF"
    ],
    "Summary Letter Date": "March 25, 2008",
    "Summary Letter Received Date": "January 25, 2008",
    "Submission Date": "January 23, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamines (d-methamphetamine)",
        "Barbiturates (secobarbital)",
        "Benzodiazepines (nordiazepam)",
        "Cannabinoids (\u03949 THC-COOH)",
        "Cocaine (benzoylecgonine)",
        "Methadone (dl-methadone)",
        "Methaqualone (methaqualone)",
        "Opiates (d-morphine)",
        "PCP (phencyclidine)",
        "Propoxyphene (propoxyphene)",
        "Amphetamines (d-amphetamine)"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Roche test system",
        "Roche Abuscreen OnLine assay for Amphetamines",
        "COBAS INTEGRA Amphetamines cobas c pack (AMPS)"
    ],
    "Method(s)/Technology(ies)": [
        "Gas chromatography/mass spectrometry (GC/MS)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Reference Material"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Control Set DAT I/II/III and Amphetamine 500/1000 assayed controls for drugs of abuse testing in urine on automated clinical chemistry analyzers",
    "Indications for Use Summary": "For use as assayed controls in the Roche system for qualitative and semiquantitative determination of drugs of abuse (including amphetamines) in human urine on automated clinical chemistry analyzers",
    "fda_folder": "Toxicology"
}